Skip to main content
Frank Slovick, MD, Oncology, Kansas City, MO

FrankTSlovickMD

Oncology Kansas City, MO

Physician

Dr. Slovick is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Slovick's full profile

Already have an account?

  • Office

    2316 E Meyer Blvd
    Kansas City, MO 64132
    Phone+1 816-276-4000
    Fax+1 816-276-3810

Education & Training

  • University of Missouri-Kansas City School of Medicine
    University of Missouri-Kansas City School of MedicineFellowship, Hematology and Medical Oncology, 1984 - 1985
  • University of Rochester
    University of RochesterResidency, Internal Medicine, 1977 - 1981
  • Perelman School of Medicine at the University of Pennsylvania
    Perelman School of Medicine at the University of PennsylvaniaClass of 1977
  • University of Pennsylvania
    University of PennsylvaniaBA, Chemistry, Summa Cum Laude, 1969 - 1973

Certifications & Licensure

  • KS State Medical License
    KS State Medical License 1988 - 2025
  • MO State Medical License
    MO State Medical License 1984 - 2025
  • NY State Medical License
    NY State Medical License 1979 - 2000
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • Awarded a James P. Wilmot Cancer Research Fellowship University of Rochester Cancer Center, 1982
  • Awarded the Dr. Spencer Morris Prize in Internal Medicine University of Pennsylvania School of Medicine, 1977
  • Alpha Omega Alpha 1976
  • Join now to see all

Publications & Presentations

PubMed

Journal Articles

  • Efficacy of Romiplostim in Patients with Chronic Immune Thrombocytopenic Purpura: A Double-blind Randomized Controlled Trial  
    Kuter DJ, Bussel JB, Lyons RM, Pullarkat V, Gersheimer TB, SenecalFM, Aledort LM, George JN, Kessler CM, Sanz MA, Liebman HA, Slovick FT, et.al., Lancet, 1/1/2008

Books/Book Chapters

Abstracts/Posters

  • Center Effects on Outcomes in the Treatment of Acute Myelogenous Leukemia (AML): A Multilevel, Community-Based, Case-Controlled Study
    Frank Thomas Slovick, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Spontaneous Clostridial Myonecrosis in a Man with Drug-induced Agranulocytosis
    Slovick FT, Bamberger D, Stark KR, Southern Medical Journal, 1/1/1988
  • Modulation of Eosinophil Progenitor Growth in Hypereosinophilic States
    Slovick FT, Abboud CN, Rowe JM, Brennan JK, Lichtman MA, Exp Hematology, 1/1/1986
  • Join now to see all

Lectures

  • Multiple Tumor Board Presentations and Discussions 
    North Kansas City Hospital - 1/1/2010
  • Unknown Primary Cancers-What's New? 
    Providence Medical Center, Kansas City, KS - 1/1/2010
  • Adjuvant Therapy for Resected Lung Cancer 
    North Kansas City Hospital - 1/1/2007
  • Join now to see all

Professional Memberships